Trade PRPO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Precipio, Inc. (PRPO) is trading at US$28.85, down 1.50% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$54.51M. Over the past 52 weeks, PRPO has traded between US$14.28 and US$33.63. On Syfe you can trade PRPO with $0 commission and add it to your watchlist.
| Previous close | US$29.29 |
|---|---|
| Market cap | US$54.51M |
| 52-week range | US$14.28 – US$33.63 |
| Volume | 205.15K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Precipio, Inc.
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. It operates through the following business divisions: Pathology Services and Products. The Pathology Services division provides specialized cancer diagnostic testing services to physicians, hospitals, and laboratories. The Products divisions develops and commercializes proprietary assays designed for use by clinical laboratories. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
Year: 2000
Precipio, Inc. (PRPO) stock is trading at US$28.85, -1.50% from the previous close of US$29.29.
The market cap for Precipio, Inc. (PRPO) stock is approximately US$54.51M.
The 52-week high for Precipio, Inc. (PRPO) stock is US$33.63.
The 52-week low for Precipio, Inc. (PRPO) stock is US$14.28.
Precipio, Inc. (PRPO) does not currently pay a dividend.
Stay on top of PRPO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
